RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway

BACKGROUND: Preoperative chemoradiation combined with surgery has been of focus recently in order to improve prognosis in esophageal squamous cell carcinoma (ESCC) patients. Finding biological markers that may assist in predicting the therapeutic effect of chemoradiation may benefit the treatment ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, De‐jun, Shi, Mo, Wang, Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129150/
https://www.ncbi.nlm.nih.gov/pubmed/27766776
http://dx.doi.org/10.1111/1759-7714.12370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129150/
https://www.ncbi.nlm.nih.gov/pubmed/27766776
http://dx.doi.org/10.1111/1759-7714.12370

Ejemplares similares